medmix AG

SWX:MEDX Stock Report

Market Cap: CHF 430.8m

medmix Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure2.3yrs
Board average tenure3.1yrs

Recent management updates

Recent updates

medmix AG's (VTX:MEDX) Business And Shares Still Trailing The Industry

Apr 04
medmix AG's (VTX:MEDX) Business And Shares Still Trailing The Industry

medmix's (VTX:MEDX) Returns On Capital Not Reflecting Well On The Business

Feb 28
medmix's (VTX:MEDX) Returns On Capital Not Reflecting Well On The Business

medmix AG (VTX:MEDX) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

Aug 11
medmix AG (VTX:MEDX) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

medmix (VTX:MEDX) Is Reinvesting At Lower Rates Of Return

Dec 19
medmix (VTX:MEDX) Is Reinvesting At Lower Rates Of Return

An Intrinsic Calculation For medmix AG (VTX:MEDX) Suggests It's 21% Undervalued

Oct 27
An Intrinsic Calculation For medmix AG (VTX:MEDX) Suggests It's 21% Undervalued

Investors Could Be Concerned With medmix's (VTX:MEDX) Returns On Capital

Aug 16
Investors Could Be Concerned With medmix's (VTX:MEDX) Returns On Capital

There May Be Reason For Hope In medmix's (VTX:MEDX) Disappointing Earnings

Feb 28
There May Be Reason For Hope In medmix's (VTX:MEDX) Disappointing Earnings

medmix (VTX:MEDX) May Have Issues Allocating Its Capital

Jan 14
medmix (VTX:MEDX) May Have Issues Allocating Its Capital

CEO

medmix has no CEO, or we have no data on them.

Leadership Team

NamePositionTenureCompensationOwnership
Jennifer Dean
Chief Financial Officer3.7yrsno data0.0048%
CHF 20.8k
Schops Xavier
Chief Legal Officerno datano data0.0023%
CHF 10.0k
Jasper Ouden
Chief Human Resources & Sustainability Officerless than a yearno datano data
Ayse Sanlioglu
Global Head of Business Unit Dental2.3yrsno datano data
Roman Thoenig
Global Head Business Segment Industryno datano datano data
Oliver Vogel
Global Head Business Segment Beautyno datano datano data
Dominik Vonier
Global Head Business Segment Drug Deliveryno datano datano data
Kara Zweizig
Head of Business Segment Surgeryno datano datano data

2.3yrs

Average Tenure

Experienced Management: MEDX's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
David Metzger
Director3.1yrsCHF 140.00k0.0039%
CHF 16.6k
Susanne Hundsbæk-Pedersen
Director1.3yrsCHF 119.00kno data
Rene Willi
Director3.1yrsCHF 3.84m0.0015%
CHF 6.5k
Marco Musetti
Independent Vice Chairman of the Board3.7yrsCHF 158.00k0.032%
CHF 137.7k
Barbara Angehrn
Independent Director3.1yrsCHF 140.00k0.0015%
CHF 6.5k
Rob Hoedt
Independent Chairman3.1yrsCHF 322.00k0.0017%
CHF 7.3k
Daniel Flammer
Director3.1yrsCHF 140.00k0.0015%
CHF 6.5k

3.1yrs

Average Tenure

55yo

Average Age

Experienced Board: MEDX's board of directors are considered experienced (3.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/02 06:56
End of Day Share Price 2025/05/02 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

medmix AG is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christoph GretlerCredit Suisse
Eugen PergerResearch Partners AG